Posts Tagged 'pancreatic cancer'

Research shows promise for distinguishing pancreas ailments

Mayo Clinic researchers say they’ve uncovered “promising” findings for a method designed to distinguish between pancreatitis and pancreatic cancer. According to a report on News-Medical.Net, the two conditions can be difficult to tell apart.

Cancer that affects the pancreas is a particularly dangerous form of the disease, with a five-year survival rate of only 5 percent. Pancreatitis, on the other hand, is an inflammation of the pancreas that can sometimes lead ...

continue reading...

Diet and exercise program helps diabetics

A study from the U.S. Centers for Disease Control and Prevention found that one in nine people with diabetes saw their blood sugar levels drop down to normal or “pre-diabetes” levels after participating in an intensive, year-long diet and exercise program, Reuters reports.

Although complete remission of Type 2 diabetes is rare, researchers say the results show promise for using lifestyle changes to get people off medication and reduce their risk ...

continue reading...

Januvia “red flags” cited by investors

In a video posted on investing Website Motley Fool, contributing writer Max Chatsko says there are a couple of “red flags” investors should be aware of regarding Merck’s bestselling Januvia/Janumet franchise for treating type 2 diabetes.

Revenue from that franchise fell 2 percent in the first quarter of 2013, compared to the same period in 2012. And while that may not seem like much, the same franchise had double-digit growth almost ...

continue reading...

Diabetes experts support Byetta, Januvia critic

A number of the world’s top diabetes experts agree with Dr. Peter C. Butler, an internationally renowned physician who raised alarms about the diabetes drugs Januvia and Byetta.

A story on MedPage Today quotes Andrew Boulton, MD, president of the European Association for the Study of Diabetes (EASD), as saying that he has the “highest respect for Peter Butler as a colleague, clinician and scientist.”

The New York Times recently ran a ...

continue reading...

Study says blood test promising for pancreatic cancer

Japanese researchers are optimistic about the results of a study suggesting that a new blood test designed to detect pancreatic cancer early may improve patients’ odds for survival.

A HealthDay News story says the improved odds are relatively small. But given the nature of pancreatic cancer, any potential improvement is good news.

The five-year survival rate for pancreatic cancer is currently less than 5 percent, in large part because it has usually ...

continue reading...

FDA panel votes to reduce Avandia restrictions

A U.S. Food and Drug Administration panel has recommended allowing the diabetes drug Avandia to remain on the market with relaxed restrictions on its use, according to NBC News.

The story says Avandia was once the world’s top-selling diabetes drug. But in 2007, an analysis of other studies suggested that it raised the risk of heart attack by 43 percent. European regulators removed it from the market in 2010 and the ...

continue reading...
Page 3 of 13 12345...»